Renaissance Capital logo

CAMP4 Therapeutics Priced, Nasdaq: CAMP

Clinical-stage biotech developing RNA-based therapies to target genetic diseases.

Industry: Health Care

Latest Trade: $11.74 0.00 (0.0%)

First Day Return: -2.5%

Return from IPO: +6.7%

Industry: Health Care

We are a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics with the goal of upregulating gene expression and restoring healthy protein levels to treat a broad range of genetic diseases. Regulatory RNAs, or regRNAs, play a central role in the regulation of every protein-coding gene by contributing to gene activation and suppression. Our approach is designed to amplify messenger RNA, or mRNA, expression by harnessing the power of regRNAs that form localized complexes with transcription factors and regulate gene expression. Our proprietary RNA Actuating Platform, or RAP Platform, allows us to rapidly and systematically identify and characterize the active regulatory elements controlling every expressed gene and tens of thousands of druggable enhancer and promoter regRNA sequences that control protein-coding genes. Once a disease-associated target gene is identified, we apply our RAP Platform to identify the controlling regRNA and rapidly generate novel antisense oligonucleotide, or ASO, candidates, which we also refer to as RNA Actuators. We are initially focused on metabolic and central nervous system, or CNS, diseases with validated disease biology, and we believe our RAP Platform allows us to address a broad range of genetic diseases in which a modest increase in protein expression has the potential to be clinically meaningful.
more less
IPO Data
IPO File Date 09/20/2024
Offer Price $11.00
Price Range $14.00 - $16.00
Offer Shares (mm) 6.8
Deal Size ($mm) $75
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 10/10/2024
Offer Price $11.00
Price Range $14.00 - $16.00
Offer Shares (mm) 6.8
Deal Size ($mm) $75
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
J.P. Morgan
Leerink Partners
more
Company Data
Headquarters Cambridge, MA, United States
Founded 2015
Employees at IPO 58
Website www.camp4tx.com

CAMP4 Therapeutics (CAMP) Performance